Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 18 - Issue 5 - May, 2006

Insights

Commentary
Sirolimus or Paclitaxel Drug-Eluting Stents for Treatment of Chronic Total Occlusions of Coronary Arteries: Much Ado about Very
08/01/2008
Phil Hemstreet, MD and H. Vernon Anderson, MD
Phil Hemstreet, MD and H. Vernon Ande...
Chronic total occlusions (CTO) represent about 10% of all coronary lesions treated by percutaneous interventions. They traditionally have posed significant problems for patients and operators, with both lower initial success rates and higher...
Chronic total occlusions (CTO) represent about 10% of all coronary lesions treated by percutaneous interventions. They traditionally have posed significant problems for patients and operators, with both lower initial success rates and higher...
Chronic total occlusions (CTO)...
08/01/2008
Journal of Invasive Cardiology

Feature

Clinical Images
Disruption of In-Stent Neointima Causing Acute Mycoardial Infarction
08/01/2008
Matthew I. Worthley, MD, *Ian Meredith, MD, Stephen Worthley, MD
Matthew I. Worthley, MD, *Ian Meredit...
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old...
08/01/2008
Journal of Invasive Cardiology
Review
Routine Pressure-Derived Fractional Flow Reserve Guidance: From Diagnostic to Everyday Practice
08/01/2008
William K. Hau, PhD
William K. Hau, PhD
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the...
08/01/2008
Journal of Invasive Cardiology
Review
Routine Pressure-Derived Fractional Flow Reserve Guidance:
From Diagnostic to Everyday Practice
08/01/2008
William K. Hau, PhD
William K. Hau, PhD
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Disruption of In-Stent Neointima Causing Acute Mycoardial Infarction
08/01/2008
Matthew I. Worthley, MD, *Ian Meredith, MD, Stephen Worthley, MD
Matthew I. Worthley, MD, *Ian Meredit...
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Evaluation of a New Polymer-Coated Paclitaxel-Eluting Stent
for Treatment of De Novo Lesions: Six-Month Clinical and Angiograph
08/01/2008
Eberhard Grube, MD, Ralf Mueller, MD, Victor Lim, MD, Thomas Schmidt, MD,Ulrich Gerckens, MD, Lutz Buellesfeld, MD
Eberhard Grube, MD, Ralf Mueller, MD...
In-stent restenosis as a result of excessive neointimal proliferation is the main limiting factor to the long-term success of coronary stenting, but the advent of drug-eluting stents has reduced this problem significantly. Paclitaxel is an...
In-stent restenosis as a result of excessive neointimal proliferation is the main limiting factor to the long-term success of coronary stenting, but the advent of drug-eluting stents has reduced this problem significantly. Paclitaxel is an...
In-stent restenosis as a result...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Angioscopically-Determined Extent of Coronary Atherosclerosis Is Associated with Severity of Acute Coronary Syndrome
08/01/2008
Yasunori Ueda, MD, PhD, Jota Oyabu, MD, Katsuki Okada, MD, Tomokazu Murakawa, MD,Atsushi Hirayama, MD, PhD, Kazuhisa Kodama, MD, PhD
Yasunori Ueda, MD, PhD, Jota Oyabu, M...
Acute myocardial infarction and unstable angina pectoris have been reported pathologically and angioscopically to share the common pathophysiology of plaque disruption with thrombosis. Both are classified as acute coronary syndromes (ACS)....
Acute myocardial infarction and unstable angina pectoris have been reported pathologically and angioscopically to share the common pathophysiology of plaque disruption with thrombosis. Both are classified as acute coronary syndromes (ACS)....
Acute myocardial infarction and...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Comparison Between Sirolimus- and Paclitaxel-Eluting Stents
for the Treatment of Chronic Total Occlusions
08/01/2008
Jae-Sik Jang, MD, Myeong-Ki Hong, MD, PhD, Cheol Whan Lee, MD, PhD, Duk-Woo Park, MD, Bong-Ki Lee, MD, Young-Hak Kim, MD, PhD, Ki-Hoon Han, MD, PhD, Jae-Joong Kim, MD, PhD, Seong-Wook Park, MD, PhD, Seung-Jung Park, MD, PhD
Jae-Sik Jang, MD, Myeong-Ki Hong, MD,...
Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions has a lower success rate and is technically demanding despite advances in equipment and operator experience.1–3 Although several studies showed favorable...
Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions has a lower success rate and is technically demanding despite advances in equipment and operator experience.1–3 Although several studies showed favorable...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Initial Experience with a Novel Coronary Rinsing and Thrombectomy System: “Rinspiration”
08/01/2008
John Webb, MDa, Mann Chandavimol, MDa, Jaap N. Hamburger, MDb, Gordon Pate, MBa, Bruce McManus, MDa, Mitch Krucoff, MDc, G.B John Mancini, MDb
John Webb, MDa, Mann Chandavimol, MD...
Percutaneous coronary intervention (PCI) plays a prominent role in the management of acute myocardial infarction (MI). However intracoronary thrombus often contributes to suboptimal angiographic results, morbidity and mortality.1 Approaches...
Percutaneous coronary intervention (PCI) plays a prominent role in the management of acute myocardial infarction (MI). However intracoronary thrombus often contributes to suboptimal angiographic results, morbidity and mortality.1 Approaches...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
A Case of Hypertrophic Obstructive Cardiomyopathy Complicated by a Single Coronary Artery Treated by Transcoronary Septal Ablati
08/01/2008
Hidehiko Hara, MD, Kazuyuki Ishii, MD, Masato Nakamura, MD
Hidehiko Hara, MD, Kazuyuki Ishii, MD...
Hypertrophic obstructive cardiomyopathy (HOCM) is a disease characterized by left ventricular hypertrophy and the presence of an outflow tract gradient. Transcoronary ablation of the septal hypertrophy (TASH) by selective transcatheter septal...
Hypertrophic obstructive cardiomyopathy (HOCM) is a disease characterized by left ventricular hypertrophy and the presence of an outflow tract gradient. Transcoronary ablation of the septal hypertrophy (TASH) by selective transcatheter septal...
Hypertrophic obstructive...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

May 2006 Volume 18 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement